Publications by authors named "Vicente Jover Cerda"

There is a profile of patient with eosinophilic oesophagitis and atopic background, marked by the existence of IgE-mediated sensitizations. Our aim is to report the observed sensitivities to environmental and food allergens and panallergens in patients with eosinophilic oesophagitis with atopic background as well as characterizing other markers or analytical parameters. We suspect that the prevalence of sensitization to panallergens will be high and this will probably be relevant in terms of the onset and clinical course of the disease.

View Article and Find Full Text PDF

Background: One of the main barriers to vaccination against SARS-CoV-2 is the fear of developing hypersensitivity reactions to any of its components. Although these reactions are very rare, it is necessary to establish an effective protocol to detect patients at risk of developing them. The aim of this study was to evaluate hypersensitivity reactions in vaccinated patients in order to allow or not to complete the vaccination protocol.

View Article and Find Full Text PDF
Article Synopsis
  • Polyethylene glycols (PEGs) and their derivatives, commonly found in various products, can trigger allergic reactions, including severe hypersensitivity reactions, despite generally being considered safe.
  • A case study describes a 29-year-old woman who experienced both local and systemic allergic reactions to multiple products containing PEG, ultimately diagnosed with IgE-mediated hypersensitivity to these compounds.
  • To help prevent allergic reactions, it is suggested that standardizing the terminology for PEGs in product labeling would aid in better identification and awareness among patients.
View Article and Find Full Text PDF

Background: Eosinophilic esophagitis (EoE) is a complex pathology. Attempts have been made in order to relate EoE with the intake of certain food. The problem is to establish which foods are really involved in the pathophysiology of this condition and to objectify a reliable inflammation biomarker for the follow-up of patients undergoing pharmacological treatment and/or diets.

View Article and Find Full Text PDF